• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCancer

A Rare Eye Cancer Has Started to Appear in 2 States

By
Emily Price
Emily Price
Down Arrow Button Icon
By
Emily Price
Emily Price
Down Arrow Button Icon
May 1, 2018, 3:24 PM ET

Three friends who attended Auburn University in Alabama have all developed the same rare eye cancer — ocular melanoma, an eye cancer that typically only affects six in every 1 million people.

If that wasn’t strange enough: One of the girls created a Facebook page, where she found 36 more people who have been diagnosed with the eye cancer — 18 in Huntersville, North Carolina, CBS News reports.

The two groups with the rare eye cancer appear to be “cancer clusters.” Researchers at the Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia are currently attempting to figure out what has caused the two cancer groupings. But the Alabama Department of Health told CBS that “it would be premature to determine that a cancer cluster exists in the area.”

Many of the patients affected by the rare eye cancer travel to the Philadelphia center for treatment, according to the report, simply because ocular melanoma is so rare that many doctors aren’t trained on how to treat it.

There is currently no cure for ocular melanoma, and treatment typically involves the removal of the eye affected by the cancer.

About the Author
By Emily Price
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.